Stock data
Cumberland Pharmaceuticals Inc. (CPIX)
Cumberland Pharmaceuticals Inc. (CPIX) reported revenue of US$44.52M and net income of -US$2.84M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$44.52M | — | -US$2.79M | -US$2.84M | — |
| 2024 | US$37.87M | — | -US$6.43M | -US$6.48M | — |
| 2023 | US$39.55M | — | -US$9.55M | -US$6.28M | — |
| 2022 | US$42.01M | — | -US$5.70M | -US$5.57M | — |
| 2021 | US$35.05M | — | -US$7.68M | -US$3.51M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$8.80M | -US$4.28M | — |
| 2026-03-31 | US$9.13M | -US$3.29M | — |
| 2025-12-31 | US$13.68M | -US$1.41M | — |
| 2025-09-30 | US$8.29M | -US$1.94M | — |
| 2025-06-30 | US$10.84M | -US$0.74M | — |
| 2025-03-31 | US$11.71M | US$1.26M | — |
| 2024-12-31 | US$10.44M | -US$1.90M | — |
| 2024-09-30 | US$9.09M | -US$1.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.